GPCRs: An update on structural approaches to drug discovery

Drug Discovery Today: TARGETS

Volumn 2, Issue 1, 2003, Pages 19-25

  Beeley, Nigel R A ^a   Sage, Carleton ^a  

^a ARENA PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIORHODOPSIN; G PROTEIN COUPLED RECEPTOR; OCTREOTIDE; RHODOPSIN; SENSORY RHODOPSIN; SEROTONIN 2C AGONIST; UROTENSIN;

ALPHA HELIX; DRUG RECEPTOR BINDING; DRUG TARGETING; GENOMICS; HIGH THROUGHPUT SCREENING; HUMAN; MOLECULAR MODEL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POINT MUTATION; PROTEIN STRUCTURE; REVIEW; SCREENING TEST; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING; X RAY CRYSTALLOGRAPHY;

EID: 3042832379     PISSN: 17418372     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1477-3627(02)02283-3     Document Type: Review

References (45)

1. Haga, T. and Berstein, G. (eds) (1999) G protein-coupled receptors. In CRC Methods in Signal Transduction Series, CRC Press
2. Heel, R.C. et al. (1979) Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs 17, 81-110
3. Tseng, L.F. et al. (eds) (2000) Opioids and Opioid Receptors, Karger
4. Jack, D. (1991) The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism : lessons from salbutamol, salmeterol and other β-adrenoceptor agonists. Br. J. Clin. Pharmacol. 31, 501-514
5. Schier, O. and Marxer, A. (1981) Antihypertensive agents 1969-1980. Prog. Drug Res. 25, 9-132
6. Wollam, G.L. et al. (1977) Antihypertensive drugs: clinical pharmacology and therapeutic use. Drugs 14, 420-460
7. Cavero, I. and Roach, A.G. (1980) The pharmacology of prazosin, a novel antihypertensive agent. Life Sci. 27, 1525-1540
8. Ganellin, R. (1981) 1980 Award in medicinal chemistry: medicinal chemistry and dynamic structure-activity analysis in the discovery of drugs acting at histamine H2 receptors. J. Med. Chem. 24, 913-920
9. Allen, F.H. (2002) The Cambridge structural database: a quarter of a million crystal structures and rising. Acta Crystallogr. 58, 380-388
10. Schleyer P.V.R. (ed.) (1998) Encyclopedia of Computational Chemistry (Vol. 5), Wiley
11. Leach, A.R. (2001) Molecular Modeling: Principles and Applications (2nd edn), Prentice Hall
12. Fersht, A. (1999) Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding, W.H. Freeman
13. Guner, O.F. (ed.) (2000) Pharmacophore perception, development and use in drug design. In IUL Biotechnology Series 2, International University Line
14. Palczewski, K. et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739-745
15. Teller, D.C. et al. (2001) Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40, 7761-7772
16. Ballesteros, J. and Palczewski, K. (2001) G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. Curr. Opin. Drug Discov. Dev. 4, 561-574
17. Pebay-Peyroula, E. et al. (1997) X-ray structure of bacteriorhodopsin at 2.5 Å from microcrystals grown in lipidic cubic phases. Science 277, 1676-1681
18. Belrhali, H. et al. (1999) Protein, lipid and water organization in bacteriorhodopsin crystals: a molecular view of the purple membrane at 1.9 Å resolution. Structure Fold. Des. 7, 909-917
19. Murzin, A.G. et al. (1995) SCOP: a structural classification of proteins database for the investigation of sequences and structures. J. Mol. Biol. 247, 536-540
20. Okada, T. et al. (1998) Highly selective separation of rhodopsin from bovine rod outer segment membranes using combination of divalent cation and alkyl(thio)glucoside. Photochem. Photobiol. 67, 495-499
21. Reeves, P.J. et al. (2002) Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc. Natl. Acad. Sci. U. S. A. 99, 13419-13424
22. Royant, A. et al. (2001) X-ray structure of sensory rhodopsin II at 2.1 Å resolution. Proc. Natl. Acad. Sci. U. S. A. 98, 10131-10136
23. Schiller, H. et al. (2001) Solubilization and purification of the human ETB endothelin receptor produced by high-level fermentation in Pichia pastoris. Receptors Channels 7, 453-469
24. Deisenhofer, J. and Michel, H. (1988) The photosynthetic reaction center from the purple bacterium Rhodopseudomonas viridis. In Nobel Lectures Chemistry, pp. 526-565
25. Lundstrom, K. (2002) Structural genomics on GPCRs: the MePNet approach. Curr. Drug Discov. May, 29-33
26. Hunte, C. and Michel, H. (2002) Crystallisation of membrane proteins mediated by antibody fragments. Curr. Opin. Struct. Biol. 12, 503-508
27. Costa-Neto, C.M. et al. (2002) Interaction of a non-peptide agonist with angiotensin II AT1 receptor mutants. Can. J. Physiol. Pharmacol. 80, 413-417
28. Laskowski, R.A. et al. (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283
29. Hatse, S. et al. (2001) Mutation of Asp-171 and Asp-262 of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100. Mol. Pharmacol. 60, 164-173
30. De Clercq, E. (2000) Inhibition of HIV infection by bicyclams, highly potent and specific CXCR4 antagonists. Mol. Pharmacol. 57, 833-839
31. Sternfeld, F. et al. (1999) Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor. J. Med. Chem. 42, 677-690
32. Archer, E. et al. (2003) Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors? Trends Pharmacol. Sci. 24, 36-40
33. Shacham, S. et al. (2001) Modeling the 3D structure of GPCRs from sequence. Med. Res. Rev. 21, 472-483
34. Jones, G. et al. (1995) Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J. Mol. Biol. 245, 43-53
35. Jones, G. et al. (1997) Development and validation of a genetic algorithm for flexible docking J. Mol. Biol. 267, 727-748
36. Adelhorst, K. et al. (1994) Structure-activity studies of glucagon-like peptide-1. J. Biol. Chem. 269, 6275-6278
37. Beeley, N.R.A. (2000) Can peptides be mimicked? Drug Discov. Today 5, 354-363
38. Gadek, T.R. et al. (2002) Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule. Science 295, 1086-1089
39. Greene, J. et al. (1994) Chemical function queries for 3D database search. J. Chem. Inf. Comput. Sci. 34, 1297-1308
40. Loretz, C.A. (1990) Recognition by goby intestine of a somatostatin analog, SMS 201-995. J. Exp. Zool. (Suppl. 4), 31-36
41. Cramer, R.D., III et al. (1988) Comparative molecular field analysis (CoMFA). Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 110, 5959
42. 2c receptor modulators: progress in development of new CNS medicines. Ann. Rep. Med. Chem. 37, 21-30
43. ROCS (Rapid Overlay of Chemical Structures) OpenEye Scientific, Santa Fe, NM, USA
44. Chalmers, D.T. and Behan, D.P. (2002) The use of constitutively active GPCRs in drug discovery and functional genomics. Nat. Rev. Drug. Discov. 1, 599-608
45. Lerner, M.R. (1994) Tools for investigating functional interactions between ligands and G-protein-coupled receptors. Trends Neurosci. 17, 142-146